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Abstract
Hepatic candidiasis is a manifestation of disseminated candidiasis, which typically presents in
immunocompromised patients. Focal hepatic candidiasis in immunocompetent patients, however, is
infrequent/extremely rare. We present the case of an immunocompetent female patient who presented with
respiratory distress and right-sided pleural effusion. The pleural fluid tap did not grow anything, and a
contrast-enhanced computed tomography (CT) scan revealed a right liver lobe subcapsular collection. CT-
guided aspiration and culture resulted in Candida albicans growth. The patient responded to oral
fluconazole, and a follow-up CT scan demonstrated resolution of the collection. Although hepatic
candidiasis rarely occurs in immunocompetent patients, it should be included in the differential diagnosis of
hepatic abscesses, as timely diagnosis and management are crucial in conferring a good prognosis.
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Introduction
Candida is a commensal yeast found predominantly in the orogastrointestinal tract [1]. Chronic
disseminated candidiasis is a form of invasive candidiasis, which most commonly affects the liver and
spleen. It typically presents in neutropenic patients with hematologic malignancies and receiving
chemotherapy [2]. However, fungal infections account for <2% of the isolates in hepatic abscesses in
immunocompetent patients [3]. Non-specific clinical presentations and low blood culture yield to identify
candida make the diagnosis a challenging prospect [4,5]. In this article, we present a case of a female patient
who presented with respiratory distress and abdominal pain as symptoms of hepatic candidiasis.
Case Presentation
A 68-year-old female patient with a past medical history of hypertension and chronic kidney disease (mild,
stage 2 with glomerular filtration rate [GFR] of 75 mL/min) presented to the emergency department with a
one-week history of dry cough and dyspnea. She had non-radiating, mild right upper quadrant abdominal
pain and nausea without vomiting. Her presenting vitals were temperature 37.2 ºC, heart rate 85 beats/min,
respiratory rate 18/min, and blood pressure 115/80 mmHg. On examination, there was mild right upper
quadrant tenderness and bronchial breath sounds in the right lower lung fields. Laboratory tests showed
leukocytosis of 34 x 109 cells/L with a neutrophilic predominance and an elevated C-reactive protein (CRP)
of 311. Liver function tests were mildly elevated, and her blood culture revealed no growth.
The chest x-ray demonstrated an obscured right costophrenic angle suggestive of minimal pleural effusion.
The diagnostic pleural tap demonstrated no growth; however, it had a white cell count of 1.7 x 109 cells/L
with a neutrophilic predominance. Contrast-enhanced computed tomography (CT) abdomen denoted a
hypodense subcapsular thick fluid density lesion in the liver's upper pole, mainly involving the right lobe of
the liver and perihepatic region (Figure 1A).
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FIGURE 1: Contrast-Enhanced CT Scan Abdomen. (A) An axial selected
section of the CT abdomen showing a hypodense fluid density
collection in the subcapsular and perihepatic region of the liver, mainly
in the right lobe (white arrows). (B) An axial selected section, from a
follow-up CT scan abdomen showing the resolution of the previously
mentioned collection.
CT - computed tomography
Prophylactic antibiotic therapy for the pyogenic liver abscess was started, and it was decided to proceed with
CT-guided drainage and abscess culture. The culture was positive for Candida albicans. The patient was
prescribed oral fluconazole, and a follow-up contrast-enhanced CT scan showed resolution of the liver
lesion or perihepatic fluid (Figure 1B). The patient improved clinically and has no recurrence of the signs
and symptoms to date.
Discussion
The etiology of liver abscesses is polymicrobial. A series of 233 patients had reported a fungal component in
22% of liver abscesses [6]. However, owing to the difficulty in diagnosis and severity of infection, it accounts
for a disproportionately high mortality rate [7]. Hepatosplenic candidiasis (HSC) almost always occurs in
patients with hematological malignancies, with an incidence of about 10%. Most commonly, HSC is seen in
acute lymphocytic leukemia, followed by acute myeloid leukemia and lymphoma [3]. Hepatic involvement is
frequently seen as part of invasive candidiasis in immunocompromised patients [7]. However, focal HSC has
also been reported. HSC in patients with no risk factors is extremely rare [8].
To date, we could only identify three reports of HSC in immunocompetent patients. Gottlieb et al. reported
an immunocompetent woman who developed Candidal hepatic abscesses as a result of pylephlebitis.
However, the causative species was Candida dubliniensis in this case [9]. Menachery et al. and Hasan et al.
both reported a solitary C. albicans liver abscess in their patients [10,11]. However, the patient reported by
Hasan et al. developed the liver abscess primarily as a complication of repeated endoscopic retrograde
cholangiopancreatography (ERCP) and subtotal cholecystectomy [11]. Furthermore, as in our patient,
respiratory symptoms as the primary presenting complaint have not been documented before, and thus
physicians should remain cognizant of this unique presentation.
Multiple identifiable factors might contribute to hepatic candidiasis' pathogenesis, including cytotoxic
chemotherapeutic regimens, prolonged use of broad-spectrum antibiotics, neutropenic conditions, and
gastrointestinal mucosal damage. Specifically, severe neutropenia, coupled with mucosal damage, can allow
Candida species to deposit in the liver and spleen. Commonly observed symptoms include persistent fever,
abdominal pain, loss of appetite, nausea, vomiting, dysphagia, and gastrointestinal bleeding [12]. The
examination can reveal oropharyngeal candidiasis, abdominal distention with right upper quadrant pain,
hepatomegaly, and rarely splenomegaly. Biochemical parameters are usually non-specific for HSC diagnosis.
Nevertheless, a high serum alkaline phosphatase and bilirubin are almost always present, and inconsistent
elevation in ALT and AST is also seen [7]. Moreover, blood cultures are negative in more than 50% of the
cases [13].
Abdominal ultrasound and a contrast-enhanced CT scan of the abdomen are the initial investigations of
choice. A contrast-enhanced CT scan is the most sensitive investigation, typically depicting multiple, round,
hypoattenuating lesions with a central enhancement. A percutaneous liver biopsy can help the definitive
diagnosis of Candida in almost three-quarters of the patients if performed [9]. A diagnostic laparoscopy
revealing white lesions on the liver surface can also aid in diagnosis [14].
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Despite the good prognosis of HSC in immunocompetent patients, a high index of clinical suspicion, repeat
imaging, or liver biopsy is needed before initiating antifungal therapy, as in our case. Amphotericin B has
been widely used as individual therapy or in combination with flucytosine [7]. Complete eradication of
hepatic candidiasis is challenging, and prolonged therapy should be considered for better outcomes. Follow-
up imaging with a contrast-enhanced CT is recommended every two to three months until the lesions'
resolution or calcification is noted [15].
Conclusions
From our case and the literature review, we conclude that hepatic candidiasis can rarely occur in
immunocompetent patients without identifiable risk factors. Physicians should not exclude hepatic
candidiasis in immunocompetent patients as a cause of the liver abscess. The diagnosis is challenging and
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